Financhill
Back

TG Therapeutics Quote, Financials, Valuation and Earnings

My #1 Coin is...

All the details are on the next page.
Buy
54

TGTX
TG Therapeutics

Last Price:
14.27
Seasonality Move:
11.61%

7 Day Trial

ALL ACCESS PASS

$ 7

Stock Market Legend Shares Biggest Prediction Ever:

Click Here to See

TG Therapeutics Price Quote

$14.27
+0.02 (+1.03%)
(Updated: April 24, 2024 at 5:39 AM ET)

TG Therapeutics Key Stats

Buy
54
TG Therapeutics (TGTX) is a Buy

Day range:
$14.17 - $14.57
52-week range:
$6.46 - $35.67
Dividend yield:
0%
P/E ratio:
158.33
P/S ratio:
9.05
P/B ratio:
13.71%

Volume:
2.9M
Avg. volume:
2.6M
1-year change:
-35.67%
Market cap:
$2.2B
Revenue:
$233.7M
EPS:
$0.01

How Much Does TG Therapeutics Make?

Is TG Therapeutics Growing As A Company?

  • What Is TG Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 548.64%
  • What Is TG Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0%

TG Therapeutics Stock Price Performance

  • Did TG Therapeutics Stock Go Up Last Month?
    TG Therapeutics share price went down by -8.01% last month
  • Did TGTX's Share Price Rise Over The Last Year?
    TGTX share price fell by -35.67% over the past 1 year

What Is TG Therapeutics 52-Week High & Low?

TG Therapeutics Price To Free Cash Flow

Data Unavailable

Is It Risky To Buy TG Therapeutics?

  • How Much Debt Does TG Therapeutics Have?
    Total long term debt quarterly is $100.1M
  • How Much Cash Does TG Therapeutics Have?
    Cash and short term investments quarterly total is $217.5M
  • What Is TG Therapeutics’s Book Value Per Share?
    Book value per share is 1.06

Is TG Therapeutics Cash Flow Positive?

  • What Is TGTX Cash Flow From Operations?
    Cash flow from operations (TTM) is -$31.4M
  • What Is TG Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is $72.7M
  • What Is TG Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is -$50.7M

TG Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    TGTX return on invested capital is 7.75%
  • What Is TG Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 4.98%
  • What Is TGTX Return On Equity?
    ROE is a measure of profitability and is 14.03%

TG Therapeutics Earnings Date & Stock Price

TG Therapeutics Competitors

  • Who Are TG Therapeutics's Competitors?
    Below is a list of companies who compete with TG Therapeutics or are related in some way:
    • Editas Medicine Inc (EDIT)
    • Amicus Therapeutics Inc (FOLD)
    • Geron Corp (GERN)
    • G1 Therapeutics Inc (GTHX)
    • Mersana Therapeutics Inc (MRSN)

TG Therapeutics Dividend Yield

Data Unavailable

TG Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 0% 11.92%
Revenue: 54863.75% 9.75%

Analyst Recommendations

Buy Recommendations: 5
Hold Recommendations: 1
Sell Recommendations: 0
Price Target: 29.75
Upside from Last Price: 108.77%

Major Shareholders

  • How many TGTX shares are owned by institutional investors?
    133M TGTX shares are owned by institutional investors
  • How many TGTX shares are owned by insiders?
    22M TGTX shares are owned by insiders